Dipraglurant Completed Phase 2 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01336088ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease